Gainers
- Merus NV MRUS shares rose 52.3 percent to $22.85 in pre-market trading. Incyte Corporation INCY and Merus announced a global strategic research collaboration to discover and develop bispecific antibodies.
- Calithera Biosciences Inc CALA rose 17.9 percent to $3.60 in pre-market trading. Bristol-Myers Squibb Co BMY and Calithera Biosciences disclosed a clinical collaboration to evaluate Opdivo in combination with CB-839 in clear cell renal cell carcinoma.
- InvenSense Inc INVN shares rose 17 percent to $12.68 in pre-market trading after TDK Corp announced plans to acquire InvenSense for $13 per share in cash.
- Lexicon Pharmaceuticals, Inc. LXRX shares rose 12.1 percent to $18.30 in pre-market trading after the company disclosed that its Phase 3 trial for sotagliflozin met its primary endpoint.
- Danaos Corporation DAC shares rose 11.1 percent to $3.00 in pre-market trading after gaining 1.85 percent on Tuesday.
- Inovio Pharmaceuticals Inc INO shares rose 11 percent to $7.69 in pre-market trading following Phase 1 Zika vaccine update.
- Winnebago Industries, Inc. WGO rose 5.9 percent to $39.40 in pre-market trading after the company reported upbeat Q1 results.
- Embraer SA (ADR) ERJ rose 5.2 percent to $18.67 in pre-market trading after declining 1.61 percent on Tuesday.
- China Eastern Airlines Corp. Ltd. (ADR) CEA rose 4.1 percent to $22.3 in pre-market trading after slipping 0.42 percent on Tuesday.
- Nike Inc NKE shares rose 2.3 percent to $53.00 in pre-market trading as the company posted stronger-than-expected results for its second quarter on Tuesday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
- xG Technology Inc XGTI shares fell 54.7 percent to $1.64 in pre-market trading after the company reported the pricing of its $10 million offering.
- Merrimack Pharmaceuticals Inc MACK fell 20.9 percent to $4.25 in pre-market trading after the company announced that it will stop a Phase 2 study of its treatment to fight breast cancer.
- Finish Line Inc FINL shares fell 14.8 percent to $19.60 in pre-market trading after the company reported weaker-than-expected results for its fiscal third quarter and issued a downbeat forecast.
- Sigma Designs Inc SIGM fell 12.9 percent to $5.05 in pre-market trading.
- RedHill Biopharma Ltd - ADR RDHL fell 12.1 percent to $9.50 in pre-market trading. RedHill Biopharma reported a proposed concurrent public offering and registered direct offering.
- Steelcase Inc. SCS shares fell 9.5 percent to $15.20 in pre-market trading after the company reported weak results for its third quarter.
- Advanced Accelerator Application SA(ADR) AAAP shares fell 8.4 percent to $24.00 in pre-market trading after the company disclosed that it has received a Complete Response Letter from the FDA for Lutathera.
- Delta Air Lines, Inc. DAL shares fell 3.5 percent to $49.00 in pre-market trading. Delta Air Lines and Aeroméxico agreed to establish a joint cooperation agreement.
- Accenture Plc ACN fell 3.3 percent to $120.00 in pre-market trading after the company issued a weak outlook for the full year.
- FedEx Corporation FDX fell 2.4 percent to $194.00 in pre-market trading after the company reported weaker-than-expected earnings for its second quarter on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMovers#PreMarket GainersBiotechnologyHealth CareLosersTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in